Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q3 2021 · 10-Q
Revenue$125.00K$125.00K±0.0% vs Q3 2020 Net Income-$5.41M-$5.41MN/M vs Q3 2020 EPS Diluted-$0.06-$0.06N/M vs Q3 2020 Operating Income-$5,061,576N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$3,845,085N/M Margins · derivedOperating margin-4049.3%−721.6 pt vs Q3 2020
Net margin-4328.4%+2128.8 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end